Cargando…
In vitro Validation of Chimeric β-Galactosylceramidase Enzymes With Improved Enzymatic Activity and Increased Secretion
Globoid Cell Leukodystrophy (GLD) is a lysosomal storage disease (LSD) caused by inherited defects of the β-galactosylceramidase (GALC) gene. The infantile forms display a rapid and aggressive central and peripheral nervous system (CNS and PNS) dysfunction. No treatments are available for GLD patien...
Autores principales: | Ricca, Alessandra, Cascino, Federica, Morena, Francesco, Martino, Sabata, Gritti, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396597/ https://www.ncbi.nlm.nih.gov/pubmed/32850960 http://dx.doi.org/10.3389/fmolb.2020.00167 |
Ejemplares similares
-
GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease
por: Senkevich, Konstantin, et al.
Publicado: (2022) -
Human iPSC-Based Models for the Development of Therapeutics Targeting Neurodegenerative Lysosomal Storage Diseases
por: Luciani, Marco, et al.
Publicado: (2020) -
β-Galactosylceramidase in cancer: more than a psychosine scavenger
por: Belleri, Mirella, et al.
Publicado: (2022) -
Isolation of a Complex Formed Between Acinetobacter baumannii HemA and HemL, Key Enzymes of Tetrapyrroles Biosynthesis
por: Nardella, Caterina, et al.
Publicado: (2019) -
Enzymatic Polymerization of PCL-PEG Co-polymers for Biomedical Applications
por: Figueiredo, Pedro, et al.
Publicado: (2019)